VMT-01

N/A

Report date: 2025/11/20 13:28:16

NME

Base Information

Drug NameVMT-01

Drug Alias Name[203Pb]VMT-01203Pb-VMT01VMT-01

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Lead > 203PbRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-MC1R

TargetsMelanocortin receptor 1

Therapy Area/IndicationsUveal melanomaSkin MelanomaMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesViewpoint Healthcare Inc Perspective Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesPerspective Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsUveal melanomaSkin MelanomaMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A